New York-based AI Doctor Startup Doctronic Bags $40 Mn Series B

Doctronic provides a 24/7 AI-powered doctor consultation service that autonomously makes clinical decisions, answers medical questions, and engages users with clinical inquiries.

New York-based startup Doctronic has raised $40 million in its Series B funding round, co-led by Abstract and Lightspeed Venture Partners. Existing investors Seven Stars, Union Square Ventures, Tusk Ventures, and Mantis also participated.

Doctronic provides a 24/7 AI-powered doctor consultation service that autonomously makes clinical decisions, answers medical questions, and engages users with clinical inquiries.

Following a $20 million Series A funding round and an additional $5 million from Union Square Ventures last year, this latest funding brings Doctronic's total capital raised to $65 million.

The company plans to use the new funds to expand its services into pediatrics and develop partnerships with academic institutions, payers, digital health platforms, and hospital systems.

In addition, Doctronic offers access to licensed physicians via video visits, available for an insurance copay or for $39 without insurance.

"Health systems see us as infrastructure, the digital front door that routes their patients efficiently and keeps care in-network. Payers see us as unlimited primary care at a predictable cost. This round lets us push further into academic medical centers, digital health platforms, and payers, while continuing to serve millions of consumers directly," Matt Pavelle, co-CEO and cofounder of Doctronic, said in a statement.

In January, the state of Utah announced a partnership with Doctronic to allow its autonomous AI system to legally renew prescriptions for patients with chronic conditions. This collaboration represents a significant development for Doctronic, which was launched in 2023, as it becomes the first AI capable of autonomously prescribing routine medication refills.

Doctronic has stated its intention to expand its prescription services beyond Utah and is engaging in discussions with regulators and government officials in other states.

In addition, proposed legislation introduced last year in the U.S. House of Representatives seeks to allow AI and machine learning technologies to autonomously prescribe drugs that have been approved by the FDA. This legislation, referred to as the "Healthy Technology Act of 2025," is sponsored by Rep. David Schweikert from Arizona.

If enacted, the bill would recognize AI as a "practitioner licensed by law to administer such drugs" and has been referred to the Committee on Energy and Commerce for further evaluation.

Stay tuned for more such updates on Digital Health News